Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huntington's Disease Rilmenidine Safety Trial
2009-018119-14Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Rilmenidine in Huntington disease (HD), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Patient safety. Started Jun 2010; status: completed.
02
Drugs
Rilmenidine
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on 2009-018119-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018119-14.